Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Is octreotide a risk factor in necrotizing enterocolitis?

Author information

Affiliations

  • 1. Long Island College Hospital, Brooklyn, NY 11201, USA.
      Authors
    • Reck-Burneo CA 1
    (1 author)

ORCIDs linked to this article

Journal of Pediatric Surgery, 01 Jun 2008, 43(6):1209-1210
https://doi.org/10.1016/j.jpedsurg.2008.02.062 PMID: 18558210 

Abstract 

Octreotide is used as a second-line treatment for hyerinsulinemic hypoglycemia in neonates who do not respond to diazoxide. We present a case of a full-term newborn with massive enterocolitis that developed after octreotide was started for the treatment of refractory hypoglycemia. Multiple intestinal resections were necessary to save intestinal length and restore intestinal function. One case has previously been reported linking the use of octreotide to the development of necrotizing enterocolitis in an infant.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/j.jpedsurg.2008.02.062

References 

Articles referenced by this article (6)

Citations & impact 

Impact metrics

20
Citations
Jump to Citations

Citations of article over time

Article citations

Go to all (20) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.